Tuesday 14 January 2025

8.00 – 9.00

Registration

8.00 – 9.00

                                                                              Welcome address

9.15 –10.15 

         Session A1: Challenges for blood supply, donor recruitment & retention (part 1)

                                                                                        Room 1

                                                                                  Hans Vrielink:
                                                       Challenges for the blood supply in Europe
                                                                 Betina Samuelsen Sørensen:
                                              Donor vigilance and challenges for blood supply

10.15 – 10.45

Coffee break

 

10.45 – 12.15

Session A1:
Challenges for blood supply,
donor recruitment & retention
(part 2)
Room 1
Nigar Ertuğrul Örüç: Recruitment
and retention of blood donors
Rodica Popa: Mapping of AI initiatives
and challenges in Europe
Norbert Niklas: Adding virtual badges
to the incentive strategy

 

Session B2: Risk-based approach
for implementing process changes
Room 2
Simonetta Pupella: Toward a common approach
to authorization of a novel blood component:
GAPP-PRO experience
Dinara Samarkanova: Expanding the use of cord
blood units for manufacturing platelet derived
products: assessment of clinical-grade products from
small units or after expiration time
Marco Amato: Stepwise process change
implementation of a buffy coat pooling protocol
to increase yields
Anita Siller: Using a hematology analyzer to count
residual cells in blood components instead of flow
cytometry

12.15 – 13.30

Lunch break (Restaurant Bleu)

 

13.30 – 15.00

Session B1: Innovative & novel blood
components (part 1)
Room 1
Peter O’Leary: Dried plasma- current
considerations in Europe
Stephen Vardy & Mike Wiltshire: Establishing
spray dried plasma as a blood component
in the UK - regulatory and scientific aspects
Melanie Robbins: Developing universal plasma
and platelets - what challenges do we need
to consider?
Antonino Calandra: Validation of umbilical cord
blood fractionation according to the «Gemelli
protocol» to obtain packed red blood cells
for transfusion in preterm infants (BORN study)

 

Session A2: Blood collection
& apheresis
Room 2
Johanna Castrén: Blood collection and apheresis
Jan Hartmann: Hypothesis-generating analysis
of active donors using a new personalized
nomogram for source plasma collection
Torunn Apelseth: Emergency collection of whole
blood – an implementation guide and report from
the Norwegian Civilian Walking Blood Bank Project

15.00 – 15.30

Coffee break

 

15.30 – 17.00

Session B1: Innovative & novel blood components (part 2)
Room 1
Torunn Apelseth: Implementation of a whole blood program for treatment of patients
with massive haemorrhage – a practical guideline for blood providers
Thibaut Bocquet: Implementation and feedback of a new method for cryopreserved platelets
with post-thaw minimal processing: the French experience
Beatrice Hechler: Cold-storage of amotosalen-UVA pathogen-reduced buffy-coat platelet concentrates for up to 21 days: biochemical and functional characterization, and identification
of emerging platelet subpopulations
Jens Altrichter: Prolonged storage of purified granulocyte concentrates from pooled buffy coats

 

17.00 – 18.30

Welcome reception (Restaurant Bleu)

 

Wednesday 15 January 2025

8.30 – 10.00

Session A3: Donor protection
Room 1
Hans Van Remoortel: How would we decide on a good plasmapheresis frequency?
Results and recommendations from the SUPPLY project
Katja van den Hurk: Whole blood donor iron management across Europe - experiences and challenges in four blood establishments
Joanne Pink: Minimising iron loss in plateletpheresis is an important component of Lifeblood’s donor iron health strategy
Amber Meulenbeld: Change in hemoglobin to identify a novel threshold for iron deficiency
- a study in blood donor populations

 

10.00 – 10.30

Coffee break

 

10.30 - 12.00

Session A4: Recipient protection & blood safety

Room 1
Johannes Blümel: Development of high throughput
sequencing for detection of viruses in blood
Jenny Mohseni Skoglund: Risk factors for carrying Trypanosoma
cruzi infection in non-endemic countries: a systematic review
Sandra Kurth: Assessment of travel related donor eligibility
in Switzerland using the online digital tool “Travelcheck”
Lisa Pate: Is antibody testing enough to protect the blood
supply from transfusion-transmitted malaria?
Jeffrey Linnen: Highly sensitive nucleic acid test for detection
of Plasmodium RNA: a potential tool to increase blood safety
and availability

 

Session B3: Novel component development
& clinical outcome monitoring

Room 2

Vanessa Agostini: Hypoxic red blood cells: an innovative
blood product
Richard Benjamin: Transfusion efficacy of amustaline/
glutathione pathogen-reduced red blood cells: results
of a randomized, controlled clinical trial
Xavier Delabranche: Free amotosalen does not induce
non-specific degranulation of basophils from healthy
volunteers in-vitro

12.00 – 13.30

Lunch break (Foyer)

 

13.30 – 15.00

Workshop: Development of innovative blood components and their authorisation/
implementation
Room 1

Linda Larsson, Ryan Evans
& Simonetta Pupella

 

Workshop:
Blood Quality Management

Room 2
Stephen Vardy & Ína Björg Hjálmarsdóttir

Workshop:
Discussion regarding deferrals based on haemoglobin/ferritin levels

Room 3
Mart Janssen, Katja van den Hurk & Amber Meulenbeld

15.00 – 15.30

Coffee break

 

15.30 – 17.00

EDQM session: Blood Guide and blood transfusion programmes

 

Room 1 Interactive discussion and Q&A